Burak Deveci is actively engaged in scientific research in the field of hematology and bone marrow transplantation. The following are key papers that highlight his contributions to modern medicine:
1. “Comparative Efficacy and Safety of Beam and Team Conditioning Regimens for Autologous Stem Cell Transplantation in Lymphoma Patients” (2023)
This study compares the efficacy and safety of two conditioning regimens, BEAM and TEAM, for lymphoma patients undergoing autologous stem cell transplantation. The results helped determine the optimal conditions for transplantation and minimize risks and complications for lymphoma patients.
2. “Safety and Efficacy of Mesenchymal Stromal Cell Therapy for Multi-Drug-Resistant Acute Graft-Versus-Host Disease” (2023)
In this study, Burak Deveci analyzed the use of mesenchymal stromal cells to treat acute reactive graft-versus-host disease (GVHD), which is resistant to standard therapies. The work showed that this therapy may be a safe and effective alternative for patients with a resistant form of GVHD, expanding the potential for therapy after bone marrow transplantation.
3. “Prolonged Viral Positivity Induced Recurrent COVID-19 Pneumonia in Patients Receiving Anti-CD20 Monoclonal Antibody Treatment” (2021)
This study looked at COVID-19 patients treated with CD20 monoclonal antibody treatment who experienced prolonged viral positivity and recurrent pneumonia. The study helped understand the mechanisms of viral persistence in cancer patients and offered recommendations for the treatment and management of these patients in a pandemic setting.